Share Search
Visit the Share Search
Life Science Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | ||
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | ||
| Millions | Millions | Millions | |||
| Income Statement | 31-12-2023 | 31-12-2022 | 31-12-2021 | ||
| Revenue | 19.96 | 15.71 | 0.53 | ||
| Operating Profit / Loss | -14.59 | -26.94 | 7.73 | ||
| Net Interest | -7.26 | -0.53 | 0.01 | ||
| Pre Tax Profit | -21.85 | -27.47 | 7.74 | ||
| Post Tax Profit | -21.71 | -27.61 | 7.74 | ||
| Profit for the Period | -21.71 | -27.61 | 7.74 | ||
| Equity Holders of Parent Company | -21.71 | -27.61 | 7.74 | ||
| Minority Interests | n/a | n/a | n/a | ||
| Continuing EPS | |||||
| Earnings per Share (Basic) | -6.20p | -7.90p | 2.20p | ||
| Earnings per Share (Diluted) | -6.20p | -7.90p | 2.20p | ||
| Earnings per Share (Adjusted) | 1.90p | 0.70p | -0.10p | ||
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -6.20p | -7.90p | 2.20p | ||
| Earnings per Share (Diluted) | -6.20p | -7.90p | 2.20p | ||
| Earnings per Share (Adjusted) | 1.90p | 0.70p | -0.10p | ||
| Dividend per Share | 2.00p | 4.00p | n/ap | ||
| Millions | Millions | Millions | |||
| Balance Sheet | 31-12-2023 | 31-12-2022 | 31-12-2021 | ||
| Non-Current Assets | |||||
| Intangible Assets | n/a | n/a | n/a | ||
| Property, Plant and Equipment | n/a | n/a | n/a | ||
| Investments | n/a | n/a | n/a | ||
| Investment Properties | 382.30 | 387.55 | 192.17 | ||
| Other Financial Assets | 4.00 | 3.87 | n/a | ||
| Other Non-Current Assets | 3.41 | 2.70 | n/a | ||
| Total Non-Current Assets | 389.71 | 394.12 | 192.17 | ||
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | ||
| Trade and Other Receivables | 6.66 | 7.66 | 3.27 | ||
| Cash at Bank and in Hand | 14.34 | 45.61 | 165.96 | ||
| Current Asset Investments | n/a | n/a | n/a | ||
| Other Current Assets | n/a | 0.43 | n/a | ||
| Total Current Assets | 21.00 | 53.70 | 169.23 | ||
| Other Assets | n/a | n/a | n/a | ||
| Total Assets | 410.70 | 447.83 | 361.40 | ||
| Current Liabilities | |||||
| Borrowings | n/a | 35.74 | n/a | ||
| Other Current Liabilities | 14.44 | 14.70 | 10.82 | ||
| Total Current Liabilities | 14.44 | 50.44 | 10.82 | ||
| Net Current Assets | n/a | n/a | n/a | ||
| Non-Current Liabilities | |||||
| Borrowings | 107.92 | 74.09 | n/a | ||
| Provisions | n/a | n/a | n/a | ||
| Other Non-Current Liabilities | 4.60 | 3.84 | n/a | ||
| Total Non-Current Liabilities | 112.52 | 77.93 | n/a | ||
| Net Assets | 283.75 | 319.45 | 350.58 | ||
| Capital and Reserves | |||||
| Share Capital | 3.50 | 3.50 | 3.50 | ||
| Share Premium Account | n/a | n/a | 339.34 | ||
| Other Reserves | 321.82 | 335.82 | n/a | ||
| Retained Earnings | -41.58 | -19.87 | 7.74 | ||
| Shareholders Funds | 283.75 | 319.45 | 350.58 | ||
| Minority Interests / Other Equity | n/a | n/a | n/a | ||
| Total Equity | 283.75 | 319.45 | 350.58 | ||
| 31-12-2023 | 31-12-2022 | 31-12-2021 | |||
| Operating Margin | -73.11% | -171.53% | 1,453.76% | ||
| Return on Capital Employed | -3.72% | -6.28% | 2.21% | ||
| Dividend Cover | 0.95 | 0.17 | n/a | ||
| Dividend Yield | 3.20 | 5.50 | n/a | ||
| PE Ratio | 33.30 | 103.30 | n/a | ||
| PEG | n/a | n/a | n/a | ||
| Dividend per Share Growth | n/a% | 100.00% | n/a% | ||
| Net Asset Value per Share | 81.07p | 91.27p | 100.17p |